Financials
- Market Capitalization 60.75 M
- Employee 128
- Founded 1983
- CEO N/A
- Website www.herontx.com
- Headquarter Delaware, United States
- FIGI BBG000G2GJT7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4173 | ELOX Eloxx Pharmaceuticals, Inc. | 15.15 USD | -5.31% | -23.29% | +13.40% | +51.50% | 61.15 M USD | ||
| 4175 | SER Serina Therapeutics, Inc. Common Stock | 2.46 USD | -4.28% | -12.77% | +18.27% | +47.75% | 62.49 M USD | ||
| 4189 | IMA ImageneBio, Inc. - Common Stock | 5.35 USD | +0.38% | -2.90% | -5.14% | -61.15% | 60.73 M USD | ||
| 4200 | DOMH Dominari Holdings Inc. - Common Stock | 2.38 USD | -4.42% | -7.75% | +0.85% | -62.22% | 57.70 M USD |
Frequently asked questions about Heron Therapeutics, Inc.
What is the Heron Therapeutics, Inc. stock price today?
The current price of Heron Therapeutics, Inc. (HRTX) is 0.32. Over the past 24 hours, the stock has changed by -3.03%. Follow the HRTX chart for real-time price dynamics.
What is the stock ticker of Heron Therapeutics, Inc.?
Heron Therapeutics, Inc. trades under the ticker HRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Heron Therapeutics, Inc. stock going up?
HRTX has changed by 0.00% over the last week, -34.69% over the last month, and -77.14% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Heron Therapeutics, Inc.?
Heron Therapeutics, Inc. currently has a market capitalization of 60.75 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Heron Therapeutics, Inc. earnings last quarter?
Last quarter, Heron Therapeutics, Inc. reported earnings of -0.03 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Heron Therapeutics, Inc. revenue for the last quarter?
Heron Therapeutics, Inc. reported quarterly revenue of 37.67 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Heron Therapeutics, Inc. net income for the last quarter?
Heron Therapeutics, Inc. reported net income of -5.49 M for the last quarter. The previous quarter showed -8.11 M, which means net income changed by +32.33%.
How many employees does Heron Therapeutics, Inc. have?
As of the latest available data, Heron Therapeutics, Inc. has 128 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Heron Therapeutics, Inc. stock?
You can buy Heron Therapeutics, Inc. (HRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Heron Therapeutics, Inc. stock?
Investing in Heron Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HRTX chart and related analysis on metatrader.com as part of your research.